Aurora Cannabis Inc. (ACB)
|Net Income (ttm)||-1.90B|
|Trading Day||February 25|
|Day's Range||10.96 - 11.71|
|52-Week Range||3.71 - 19.68|
The cannabis producer has been making progress -- but is it enough to win over hesitant investors?
The bubble pop is moving quickly from sector to sector as marijuana stocks took center stage in one of the biggest and quickest to rise and fall recently. The post 7 Marijuana Stocks That Coul...
Pot stocks surrendered some of their recent gains amid a broad market sell-off.
CRON stock stands to gain from state-level cannabis legalization as well as from speculation around federal legalization. The post Cronos Group and Other Cannabis Stocks Could See Higher Highs...
After doing some good on its promise of a comeback, Aurora has encountered yet another roadblock.
The ETFMG Alternative Harvest ETF (NYSE: MJ) traded lower on Monday as investors continued to take profits on the post-election run-up in cannabis stocks. This week is a big week in the cannab...
Marijuana stocks have outpaced the broader market so far this year and the gains could continue as retail investors pile in. The post 4 Marijuana Stocks That Are Surging appeared first on Inve...
The ACB stock price has gone sky-high in 2021, but Q2 results showed little fundamental reason to support further gains. The post Aurora Cannabis Is Speculative — And It Might Take a Breather ...
The ETFMG Alternative Harvest ETF (NYSE: MJ) rebounded by 3.1% on Friday to around $25, but the find is still way off its February high of near $35. On Friday, DataTrek Research co-founder Jes...
Why Canadian pot stocks are higher than U.S. pot stocks, despite legislative wins
Vivian Azer, Cowen managing director, joins 'Power Lunch' to discuss the boom in pot stocks and why Canadian cannabis stocks are higher than U.S. cannabis stocks despite legislative changes in...
ACB stock won't get a major boost until Aurora Cannabis can report positive free cash flow. Here's what investors should do with ACB stock.
Thanks to some new partnerships and the Reddit market frenzy, ACB stock experienced a nice bump. That doesn't mean it's sustainable.
ACB stock fell after earnings, and with good reason. Still-significant losses and weak growth mean investors should look elsewhere in the sector.
Investors, it seems, are sobering up about the weed industry after pushing its stocks high over the past few days.
More consolidation in the sector and large pension fund investment have investors betting on Aurora.
Meme stocks can be hard to time. But one thing is clear -- they will dominate the news in 2021.
The shares of several cannabis companies are trading higher Tuesday as retail investor interest continues to drive the sector higher. The election of Joe Biden as U.S. President and recent Dem...
Pot stock investors won't be seeing green if they keep this up.
We've seen this story before, and it didn't end well for pot stock investors on the first go-round.
One analyst says the marijuana company's investors could incur brutal losses.
Welcome back to our weekly series, Sc haeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week, and look ahead to how the cannabis industry...
Volatility continues in cannabis stocks as quarterly earnings begin to filter in.
Investors should continue sticking to the sidelines when it comes to Aurora Cannabis Inc (NYSE: ACB). That's according to a Cantor Fitzgerald analyst, citing the sales and EBITDA miss in the c...
With the trading day roughly halfway over, the broad markets were sliding into the weekend.
How the Reddit-fueled volatility around pot stocks affect marijuana legalization efforts
CNBC's "Squawk on the Street" team discusses pot stocks with Sen. Tom Daschle, Clever Leafs advisory board member and former Senate Majority Leader, and Kyle Detwiler, Clever Leaves CEO.
Pot producer Aurora Cannabis Inc (NYSE:ACB) is down 9% at $13.17 in pre-market trading, after receiving a downgrade from MKM Partners to "sell" in the wake of a disappointing fiscal second-qua...
Core business is strong regardless of market volatility: Aurora CEO
Miguel Martin, CEO of Aurora Cannabis, joins "Squawk Box" to discuss the Reddit-fueled market volatility in cannabis stocks and the strength of the business broadly.
The sector is hot again on the heels of two large deals.
Aurora Cannabis Inc. (ACB) delivered earnings and revenue surprises of -47.37% and -4.99%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for t...
Aurora Cannabis (NYSE:ACB) released its second-quarter fiscal 2021 earnings report Thursday afternoon. Here's what we learned: Total cannabis net revenue hovered $70.3 million, excluding provi...
The company showed encouraging growth in the stronger of its two main product categories.
Canaccord Genuity analyst says there's 'exuberance' in markets, driving cannabis stock higher
Matt Bottomley from Canaccord Genuity says there's a lot of exuberance coming into the market that may be moving the cannabis stock higher. He joins 'Closing Bell' to discuss his takeaways on ...
Traders are bailing out of pot stocks. But should they be?
The glory days for marijuana stocks began in late 2017 and early 2018. Then in September of 2018, the bottom began to fall out of the market for these stocks, and by March of 2020, shares were...
MGC Pharmaceuticals Ltd (LON:MXC) shares, fresh from their London debut, have been caught up in a Reddit-led rush into cannabis-focused companies. Looking for their next stocks to buy after li...
Aurora Cannabis will report fiscal second-quarter earnings, amid a broader marijuana stocks rally aided by U.S. legalization prospects. The post Aurora Cannabis To Report As Huge Rally In Mari...
The group of cannabis companies are garnering attention from the same WallStreetBets Reddit army that contributed to the epic short squeeze in GameStop last month.
Bradley Tusk says there's reason to be optimistic on cannabis industry
Bradley Tusk, CEO of Tusk Ventures, says it's likely there will be some retail investors who lose money by investing in the cannabis industry, similar to GameStop stocks. But he says there's a...
Navy Capital CEO on Reddit investor interest in the cannabis stocks
Navy Capital is a firm that manages approximately $375 million in cannabis-related stocks. Sean Stiefel, Navy Capital CEO, joins 'Closing Bell' to discuss the recent increase in retail investo...
Analysts seem confused about whether Canopy's Q3 earnings were good or bad.
Even though this is the busiest week for companies reporting quarterly earnings in this go-round, most of the results already have been released.
He's not nearly as bullish on legalization as some people are.
Cannabis industry stocks soared on Tuesday as industry leaders made groovy predictions about their financial prospects and marijuana legalization in Washington. Shares in Canadian grower Tilra...
Canopy promises investors a profit, but didn't quite deliver it this time.
Good news for the cannabis industry is standing out on a calm market day.
Cannabis stocks like SNDL, CGC and TLRY stock are on the move Monday after Tilray announced a medical marijuana distribution deal. The post Cannabis Stocks: Why TLRY, CGC, APHA, ACB and SNDL A...
Its stock price has gone sky high so far this year -- but has Aurora really done anything to merit the boost, or is it a fluke?
The U.S. Cold War against cannabis is rapidly thawing.
There's no need to load the boat on ACB stock now. Instead, consider trying out a small position in hopes of full U.S. cannabis legalization.
Aurora Cannabis produces and distributes medical cannabis products worldwide. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, including facility engineering and design, cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients. It also sells vaporizers; consumable vaporiz... [Read more...]
Drug Manufacturers-Specialty & Generic
|Stock Exchange |
|Ticker Symbol |
In 2020, ACB's revenue was 278.91 million, an increase of 13.59% compared to the previous year's 245.54 million. Losses were -3.37 billion, 951.4% more than in 2019.